ELAN
ELAN
NYSE · Pharmaceuticals

Elanco Animal Health Inc

$24.90
+0.46 (+1.88%)
As of Mar 24, 9:43 PM ET ·
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Buy 20 91%
Hold 2 9%
Sell 0 0%
Price Target
Analyst Price Target +595.7% upside
Low Target $121.49
Average Target $173.23
High Target $230.47
Current Price $24.90
Current
$24.90
Target
$173.23
$121.49 $173.23 avg $230.47
Scenario Analysis
Bear Case
$121.49
387.9%
Low target
Base Case
$173.23
+595.7%
Avg target
Bull Case
$230.47
+825.6%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$27.72
-10.2% from high
52-Week Low
$8.02
+210.5% from low
50-Day SMA
$23.56
+5.7% vs SMA
200-Day SMA
$18.91
+31.7% vs SMA
RSI (14)
59.1
Neutral
Target vs 52W High
$173.23
+524.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +47.3%
JNJ
Johnson & Johnson
Buy 32 59% $299.55 +27.3%
MRK
Merck & Co. Inc.
Buy 36 67% $159.27 +36.9%
PFE
Pfizer Inc.
Hold 35 40% $33.90 +25.7%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +204.1%
ZTS
Zoetis Inc
Buy 25 64% $209.87 +81.0%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -20.4%
VTRS
Viatris Inc
Buy 18 67% $122.82 +819.3%